Skip to main content

Table 3 Regression analysis for CI-AKI predictors of the first agent

From: Predictors of contrast-induced acute kidney injury in patients with coronary artery disease receiving contrast agents twice within 30 days

VariableUnivariate analysisMultivariate analysis
P valueOR95% CIP value
Female0.8541.0260.424–2.4840.954
NYHA Class II-III0.0041.3260.542–3.2480.536
Hypertension0.6261.6710.736–3.7960.220
Diabetes0.2761.1790.483–2.8760.718
Diuretics< 0.0013.7611.462–9.6750.006
CCB0.2280.2690.086–1.8380.240
β-RB0.7150.3990.157–1.0110.053
ACEI/ARB0.7570.5750.240–1.3770.214
Statins0.5180.6430.097–3.3040.390
Digitalis0.0101.5880.608–4.1490.345
IABP< 0.0014.2451.378–13.0830.012
LM lesion0.7160.5640.256–1.2410.155
Age0.3811.0000.965–1.0350.983
Basic SYNTAX score0.0780.9960.946–1.0470.861
  1. NYHA New York Heart Association, CCB Calcium channel blocker, β-RB β-receptor blocker, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor antagonist, IABP Intra-aortic balloon pump, LM Left main, SYNTAX Synergy between percutaneous coronary intervention with Taxus and cardiac surgery